Back to Products
Tablet
DROMISET-M
Drotaverine (80 mg), Mefenamic Acid (250 mg)
Ramitra Biotech presents DROMISET-M, containing Drotaverine (80 mg), Mefenamic Acid (250 mg), a high-trust Tablet in 10 x 10 Aluminium packing validated for quality assurance and certified under WHO-GMP protocols for healthcare providers across India.
📋 Specifications
| Product Name | DROMISET-M |
|---|---|
| Composition | Drotaverine (80 mg), Mefenamic Acid (250 mg) |
| Category | Tablet |
| Packaging | 10 x 10 Aluminium |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
DROMISET-M offers a potent and synergistic combination of Drotaverine 80 mg and Mefenamic Acid 250 mg, engineered for rapid pain relief.
This dual-action formulation effectively addresses both smooth muscle spasms and associated inflammatory processes.
Provides effective management for severe pain associated with gastrointestinal and abdominal spasms, irritable bowel syndrome, dysmenorrhea, and renal colic.
Ensures comprehensive pain management by simultaneously targeting cramping and inflammation for sustained symptomatic relief.
A trusted formulation delivering prompt and sustained symptomatic relief in a convenient tablet form.
Quantity
